Sitting in patients with spinal muscular atrophy type 1 treated with nusinersen
<p><strong>Aim</strong> To determine factors associated with acquisition of a sitting position in patients with spinal muscular atrophy type 1 (SMA1) treated with nusinersen.</p> <p><strong>Method</strong> Using data from the registry of patients with SMA1...
Main Authors: | Aragon-Gawinska, K, Daron, A, Ulinici, A, Vanden Brande, L, Seferian, A, Gidaro, T, Scoto, M, Deconinck, N, Servais, L, SMA-Registry Study Group |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Wiley
2019
|
Similar Items
-
Nusinersen treatment of spinal muscular atrophy: current knowledge and existing gaps
by: Gidaro, T, et al.
Published: (2018) -
Nusinersen in patients older than 7 months with spinal muscular atrophy type 1: A cohort study
by: Aragon-Gawinska, K, et al.
Published: (2018) -
Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
by: Finkel, RS, et al.
Published: (2017) -
Spinal Muscular Atrophy Treatment in Patients Identified by Newborn Screening—A Systematic Review
by: Karolina Aragon-Gawinska, et al.
Published: (2023-06-01) -
Nusinersen mitigates neuroinflammation in severe spinal muscular atrophy patients
by: Tommaso Nuzzo, et al.
Published: (2023-02-01)